Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M703157200 on May 16, 2007

J. Biol. Chem., Vol. 282, Issue 29, 20925-20932, July 20, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/29/20925    most recent
M703157200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maksumova, L.
Right arrow Articles by Johnson, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maksumova, L.
Right arrow Articles by Johnson, P.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Differential Function of PTP{alpha} and PTP{alpha} Y789F in T Cells and Regulation of PTP{alpha} Phosphorylation at Tyr-789 by CD45*

Lola Maksumova{ddagger}1, Yanni Wang§, Nelson K. Y. Wong§, Hoa T. Le2, Catherine J. Pallen{ddagger}3, and Pauline Johnson§4

From the Departments of {ddagger}Pediatrics, §Microbiology and Immunology, and Pathology and Laboratory Medicine, University of British Columbia and Child & Family Research Institute, Vancouver, British Columbia V6T 1Z3, Canada

Received for publication, April 13, 2007 , and in revised form, May 14, 2007.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
CD45 is a major membrane protein tyrosine phosphatase (PTP) expressed in T cells where it regulates the activity of Lck, a Src family kinase important for T cell receptor-mediated activation. PTP{alpha} is a more widely expressed transmembrane PTP that has been shown to regulate the Src family kinases, Src and Fyn, and is also present in T cells. Here, PTP{alpha} was phosphorylated at Tyr-789 in CD45– T cells but not in CD45+ T cells suggesting that CD45 could regulate the phosphorylation of PTP{alpha} at this site. Furthermore, CD45 could directly dephosphorylate PTP{alpha} in vitro. Expression of PTP{alpha} and PTP{alpha}-Y789F in T cells revealed that the mutant had a reduced ability to decrease Fyn and Cbp phosphorylation, to regulate the kinase activity of Fyn, and to restore T cell receptor-induced signaling events when compared with PTP{alpha}. Conversely, this mutant had an increased ability to prevent Pyk2 phosphorylation and CD44-mediated cell spreading when compared with PTP{alpha}. These data demonstrate distinct activities of PTP{alpha} and PTP{alpha}-Y789F in T cells and identify CD45 as a regulator of PTP{alpha} phosphorylation at tyrosine 789 in T cells.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Protein tyrosine phosphatases (PTPs)5, together with protein tyrosine kinases, are responsible for controlling the level of tyrosine phosphorylation within cells. In general, basal tyrosine phosphorylation levels in unstimulated cells are relatively low, suggesting that protein tyrosine phosphatase activity prevails over tyrosine kinase activities under resting conditions. Stimulation of cells via a variety of receptors linked to tyrosine kinases can induce tyrosine phosphorylation cascades that lead to cell activation or modulation of cellular function. In T lymphocytes, CD45 is a major protein tyrosine phosphatase expressed at the T cell membrane where it is thought to contribute over 90% of the membrane-associated PTP activity (1). Recognition of antigen by the T cell receptor (TCR) results in induction of a tyrosine phosphorylation cascade leading to T cell activation and is driven primarily by the activity of the Src family kinase (SFK), Lck (2). Counter-intuitively, CD45 is required for the efficient progression of this TCR-induced tyrosine phosphorylation signal, as it is required to dephosphorylate the negative regulatory site (Tyr-505) of Lck (reviewed in Refs. 3–5). This relieves inhibitory constraints on Lck and primes it for subsequent autophosphorylation at tyrosine 394 and activation. This activating function of CD45 and its requirement for efficient TCR signaling are well established. However, evidence from CD45–/– thymocytes and certain CD45– T cell lines indicates that the absence of CD45 can result in enhanced Lck phosphorylation at both the negative regulatory and autophosphorylation sites, suggesting a role for CD45 in both the activation and inactivation of Lck (4, 6, and reviewed in Ref. 7). Thus the function of CD45 may be to keep Lck under control, allowing activation, but preventing sustained activation or inactivation. It has been difficult to examine the role of CD45 in inactivating Lck and down-regulating TCR signaling because CD45 is also needed for activation. However, antibody cross-linking of CD4 and CD44 can result in Lck activation independently of CD45, thereby allowing observation of the inactivating role of CD45 and its dephosphorylation of Tyr-394 on Lck (8–10). CD45 has also been reported to affect the phosphorylation state of Fyn in T cells (11); although this effect has always been less pronounced than for Lck. Likewise, although Fyn has been implicated in TCR signaling events, its effect on TCR signaling events is less dramatic than that of Lck (12).

SFKs are widely expressed, whereas CD45 expression is restricted to leukocytes, indicating that other PTPs must regulate these enzymes in other cell types. PTP{alpha} has been shown to dephosphorylate the negative regulatory site of Src and Fyn in other cell types, whereas cytosolic PTPs such as SHP-1, -2, PEP, and PTP1B have been implicated in dephosphorylation at the autophosphorylation site (13 and reviewed in Ref. 14). Some of these PTPs are also present in T cells where they have been shown to modulate SFK phosphorylation, indicating that regulation of SFKs can be controlled by multiple phosphatases. Although expression of PTP{alpha} in a CD45– T cell line did not substantially affect Lck or Fyn phosphorylation, it did partially restore CD3-mediated TCR signaling events, suggesting that it can partially substitute for some CD45 activities (15). A comparison of CD45 and PTP{alpha} activities revealed that PTP{alpha} was a much less active PTP under the in vitro conditions tested. Furthermore, analysis of thymocyte development and T cell activation in PTP{alpha}–/– mice revealed a role for PTP{alpha} in the dephosphorylation and regulation of lipid raft-associated Fyn and its substrate, Cbp (16). This raises the possibility that both CD45 and PTP{alpha} contribute to the regulation of SFKs in T cells, and this study was performed to evaluate the contributions of each phosphatase. Surprisingly, we found that CD45 regulates the phosphorylation of PTP{alpha} at Tyr-789, a regulatory site that influences the ability of PTP{alpha} to dephosphorylate SFK (17).


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Cells—BW5147 CD45+ and CD45– mouse T lymphoma cells (CD45+ and CD45– T cells) expressing TCR/CD3 and PTP{alpha} were described previously (15). VSVG-tagged forms of PTP{alpha} (18) and PTP{alpha}-Y789F were transfected into CD45+ and CD45– T cells and sorted for high expression. Cells were maintained in Dulbecco's modified Eagle's medium with 10% (v/v) horse serum supplemented with 100 µg/ml streptomycin-penicillin, 3 mM histidinol (Sigma), and 1 mg/ml G418 (Invitrogen) to maintain the expression of TCR/CD3 and PTP{alpha}, respectively. Thymocytes and splenocytes were isolated from C57Bl/6 mice and CD45–/– mice (19).

Reagents and Antibodies—Purified recombinant His6-tagged murine CD45 cytoplasmic domain proteins were described previously (20, 21). Anti-PTP{alpha} rabbit antisera (22), anti-Lck (BD Transduction Laboratories or R54-3B, 23), anti-CD45 cytoplasmic domain antisera (RO2.2) (20), CD44 mAb (KM81) from J. Lesley, VSVG mAb (Sigma), CD3 mAb, 2C11 (ATCC), phosphotyrosine mAbs, 4G10 and PY20 (Millipore), Fyn-3G, Zap-70, phospho-Zap-70 (Tyr-319) (Cell Signaling) Pyk2, Grb2, Csk antibodies (Santa Cruz Biotechnology), Fyn (BD Transduction Laboratories) phospho-Tyr-529 Fyn (Biosource International), and anti-Cbp antisera (24) were used. Protein A-conjugated HRP (Bio-Rad) and goat anti-mouse IgG HRP (Southern Biotechnology) were used in Western blots.

Immunoprecipitation and Immunoblotting—Cells were lysed in either 1% Triton X-100 with 150 mM NaCl or KCl, 20 mM Tris-HCl (pH 7.5), 2 mM EDTA or radioimmune precipitation assay buffer, with 0.5 mM sodium orthovanadate, 0.2 mM sodium molybdate, 0.2 mM phenylmethanesulfonyl fluoride, 1 mg/ml leupeptin, 1 mg/ml aprotinin, and 1 mg/ml pepstatin. Cell lysates were incubated on ice for 20 min and then centrifuged at 14,000 x g for 10 min at 4 °C. PTP{alpha}, Fyn, Lck, Cbp, or Pyk2 was immunoprecipitated from CD45+ and CD45– T cells, thymocytes, or splenocytes, essentially as described previously (9, 15, 16). Samples were analyzed on 10% acrylamide gels by SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membrane (Immobilon P, Millipore). PTP{alpha}, Fyn, p529 Fyn, Cbp, Lck, and Pyk2 were identified by immunoblotting with the respective antibodies and the overall tyrosine phosphorylation state identified by 4G10 mAb followed by protein A HRP or anti-mouse IgG-HRP. Blots were developed using ECL or ECL plus (Amersham Biosciences) and exposed to BioMax Film from Eastman Kodak Co.

In Vitro Dephosphorylation Assay—PTP{alpha} and Lck were immunoprecipitated from CD45– T cells transfected with PTP{alpha} as described above. Immune complexes bound to beads were washed three times with cold PTP buffer (50 mM Tris, pH 7.2, 1 mM EDTA, 0.1% beta-mercaptoethanol) and then incubated with 400 ng (20 µl) of purified recombinant His6-CD45 or His6-CD45C817S proteins at 30 °C from 0 to 10 min. The reactions were stopped by immersion in a dry ice/ethanol bath, and addition of 10 µl of 3X reducing sample buffer. Samples were electrophoresed on a 10% SDS-PAGE and transferred to PVDF. The amount of phosphorylated PTP{alpha} or Lck remaining was detected by 4G10 (1:5000) and goat anti-mouse-HRP or protein A-HRP. The tyrosine-phosphorylated bands were analyzed by densitometric analysis using AlphaimagerTM software. The amount of tyrosine phosphorylation per unit PTP{alpha} at time 0 was taken as 100%.

Kinase Assay—Fyn was immunoprecipitated from 300 to 400 µg of protein lysate. The kinase activity of these immunoprecipitates was determined in 20 µl of kinase buffer containing 10 mM PIPES, pH 7, 5 mM MnCl2, 0.5 mM dithiothreitol, and 10 µCi [{gamma}-32P]ATP, and with or without 0.2 unit of enolase (Sigma) at 30 °C for 10 min (18). The enolase was treated with 10-mM sodium acetate, pH 3.5, at 37 °C for 5 min prior adding to the kinase buffer. Reactions were terminated by adding 20 µl of 2x SDS sample buffer, boiled for 5 min, and subjected to SDS-PAGE. The SDS-PAGE gels were dried and autoradiographed. Another set of immunoprecipitates was immunoblotted with anti-Fyn antibodies to determine the amount of immunoprecipitated protein (data not shown).

TCR/CD3 Stimulation—This was performed essentially as described (16).

Cell Spreading Assay—Untransfected and PTP{alpha} transfected CD45– T cells were immobilized on anti-CD44 mAb, essentially as described (9). After 2 h of incubation at 37 °C, the cells were fixed with 4% paraformaldehyde and the cell length measured. The two-tailed t test was used to determine statistical significance.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
PTP{alpha} Is Tyrosine Phosphorylated in T Cells Lacking CD45—Transfection of PTP{alpha} into CD45+ and CD45– BW5147 T lymphoma cells (hereafter referred to as CD45+ and CD45– T cells, respectively) and selection of PTP{alpha} positive clones revealed that PTP{alpha} was tyrosine phosphorylated in CD45– T cells, but not in CD45+ T cells (Fig. 1A). Because PTP{alpha} is constitutively phosphorylated at tyrosine 789 in NIH 3T3 fibroblasts (25), PTP{alpha}-Y789F was expressed in CD45+ and CD45– T cells. This mutated form of PTP{alpha} was not tyrosine phosphorylated in CD45– T cells (Fig. 1A), inferring that PTP{alpha} was phosphorylated at tyrosine 789 in CD45– T cells. It also suggested that the presence of CD45 facilitated dephosphorylation of PTP{alpha} at Tyr-789. To determine whether CD45 was able to regulate the phosphorylation state of endogenous PTP{alpha} in T cells, the phosphorylation state of PTP{alpha} was examined in thymocytes and splenocytes from CD45 positive (CD45+/+, C57Bl/6), and CD45 null (CD45–/–) mice (19). Fig. 1B shows that the phosphorylation of endogenous PTP{alpha} in both thymocytes and splenocytes isolated from CD45–/– mice was significantly higher than from CD45+/+ cells. These data strongly suggest an unexpected role for CD45 in regulating PTP{alpha} phosphorylation in T cells.


Figure 1
View larger version (66K):
[in this window]
[in a new window]

  		FIGURE 1.
Phosphorylation state of PTP{alpha} from CD45+ and CD45– T cells. A, immunoprecipitation of PTP{alpha} from 500 µg of protein from cells lysed in 1% Triton X-100 from untransfected (parent), PTP{alpha}-transfected (two clones, {alpha}3. 1 and {alpha}7.5, in CD45+ cells and two clones, {alpha}3.11 and {alpha}2.10, in CD45– cells), and PTP{alpha}-Y789F transfected (Y789F) CD45+ and CD45– BW5147 T cells. The immunoprecipitates were immunoblotted for phosphotyrosine with 4G10 (PY-PTP{alpha}, top panel) and for PTP{alpha} (middle panel). The lower panel is an immunoblot of the cell lysate with CD45. B, immunoprecipitation of PTP{alpha} from 2 mg of protein from thymocyte (Thy) and splenocyte (Spl) lysates isolated from C57Bl/6 (+/+) and CD45–/– null mice (–/–). The immunoprecipitates were immunoblotted for phosphotyrosine with 4G10 (PY-PTP{alpha}, top panels) and for PTP{alpha} (middle panels). The lower panels are immunoblots for CD45 to indicate the expression of CD45 in the cell lysates. The experiment was repeated three times.

 
CD45 Can Directly Dephosphorylate Tyrosine 789 of PTP{alpha} in Vitro—To determine whether CD45 was able to directly dephosphorylate PTP{alpha} at tyrosine 789, dephosphorylation of phosphorylated PTP{alpha} was examined in vitro. Purified active recombinant CD45 cytoplasmic domain (aCD45) or mutated inactive rCD45cytC817S (iCD45; 20) were used to dephosphorylate PTP{alpha} immunoprecipitated from CD45– T cells. This was compared with immunoprecipitated Lck, a well established substrate of CD45 in T cells. Active, recombinant CD45 (a CD45) dephosphorylated PTP{alpha} at a rate similar to that of Lck (Fig. 2, A and B). Importantly, no significant dephosphorylation was observed in the presence of inactive CD45, indicating that PTP{alpha} itself was not making a substantial contribution to its own dephosphorylation. This is also consistent with the inability of PTP{alpha} to dephosphorylate itself in CD45– T cells. These in vitro data indicate that CD45 can efficiently and directly dephosphorylate PTP{alpha} and raise the possibility that CD45 may directly dephosphorylate PTP{alpha} at tyrosine 789 in T cells.

Tyrosine Phosphorylation of PTP{alpha} Is Significantly Reduced by the SFK Inhibitor, PP2—Src has been implicated in the phosphorylation of tyrosine 789 of PTP{alpha} (25, 26). As CD45 can both up- and down-regulate SFK activity in T cells (7, 27), it is possible that CD45 could also regulate PTP{alpha} phosphorylation indirectly by negatively regulating SFK activity. To determine whether SFK activity can regulate tyrosine 789 phosphorylation of PTP{alpha}, transfected CD45+ and CD45– T cells were treated with 10 µM PP2, a SFK inhibitor (28) and the phosphorylation state of PTP{alpha} examined. Fig. 2C indicates that the tyrosine phosphorylation of PTP{alpha} in CD45– T cells was significantly reduced after 30 min of treatment with PP2 but not with the inactive PP2 analogue, PP3. These results implicate SFK activity in the phosphorylation of tyrosine 789.


Figure 2
View larger version (31K):
[in this window]
[in a new window]

  		FIGURE 2.
In Vitro dephosphorylation of PTP{alpha} by recombinant CD45. A, recombinant active CD45 cytoplasmic domain protein (aCD45) and the inactive C817S mutant (iCD45) were added to PTP{alpha} and Lck immunoprecipitated from 2 x 106 CD45– T cells and incubated for the times indicated. The reaction was stopped in a dry ice/ethanol bath and the proteins separated on a 10% SDS-polyacrylamide gel and transferred to PVDF membrane. The extent of dephosphorylation of PTP{alpha} and Lck, as well as the amount of PTP{alpha} and Lck present in the immunoprecipitate, was detected by immunoblotting for phosphotyrosine with 4G10 (PY), PTP{alpha}, and Lck antibodies, respectively. B, graphical representation of the extent of dephosphorylation over time with either active rCD45 (a) or inactive rCD45 (i). Densitometric analysis of Western blots from three to four experiments was performed, and the relative phosphotyrosine per unit protein (%PY) was plotted over time. The value at time 0 for inactive CD45 was taken as 100%. Values represent the average of three experiments ± S.D. C, CD45+ and CD45– T cells transfected with PTP{alpha} (wt {alpha}) were treated with 10 µM active (PP2) or inactive (PP3) inhibitor of SFK for 30 min, lysed, and PTP{alpha} immunoprecipitates were resolved by SDS-PAGE. Immunoblots were probed with anti-phosphotyrosine (4G10, PY-PTP{alpha}) and PTP{alpha} antibodies (lower panel). This experiment was repeated three times.

 


Figure 3
View larger version (40K):
[in this window]
[in a new window]

  		FIGURE 3.
Effect of PTP{alpha} on the phosphorylation state of Fyn, Lck, and Cbp. A, Fyn and Lck were immunoprecipitated from equal amounts of protein from parental CD45+ and CD45– T cells as well as from PTP{alpha} transfected (WT {alpha}) and PTP{alpha}-Y789F (Y789F) transfected CD45+ and CD45– T cells lysed in radioimmune precipitation assay buffer, and their phosphorylation states determined with the phosphotyrosine mAb 4G10 (PY). Alternatively, the membranes were stripped and reprobed with a phospho-site specific antisera (Biosource International) that recognizes the phosphorylated negative regulatory site of Fyn (pTyr529 Fyn). Membranes were then stripped and reprobed with Fyn or Lck antibodies to determine the amount of immunoprecipitated kinase. B, immunoprecipitated Fyn was assayed for in vitro kinase activity, and a representative autoradiograph is shown (top panel). Arrows indicate (from top to bottom) a phosphorylated Fyn-associated protein, Fyn, IgG, and enolase. Immunoprecipitated Cbp was probed with 4G10 (PY) to determine its level of tyrosine phosphorylation and was subsequently reprobed for the Cbp-associated kinase, Csk, and then for Cbp itself (three middle panels). The amounts of PTP{alpha}, VSVG-tagged PTP{alpha}, and CD45 in the cells were determined by immunoblotting cell lysates (three bottom panels). Experiments were repeated at least three times.

 
Differential Effect of PTP{alpha} and PTP{alpha}-Y789F on the Phosphorylation State of Fyn and Cbp in CD45– T Cells—Having established that the presence of CD45 affects the phosphorylation state of tyrosine 789 in PTP{alpha}, we investigated whether the Y789F mutation, which prevents phosphorylation at this site, affected the function of PTP{alpha}. To do this, we examined the effect of PTP{alpha} and PTP{alpha}-Y789F in CD45+ and CD45– T cells. As PTP{alpha} has been shown to regulate the SFK Fyn and phosphorylation of Cbp in thymocytes (16), we first examined these in the transfected CD45+ and CD45– T cells sorted for high expression of VSVG-tagged PTP{alpha}. Fyn was immunoprecipitated from parental PTP{alpha} and PTP{alpha}-Y789F transfected cells and its tyrosine phosphorylation state compared with that of Lck, the other SFK expressed in T cells. Both Fyn and Lck were hyperphosphorylated in the CD45– T cells compared with CD45+ T cells, consistent with a role for CD45 in dephosphorylating these SFKs, as has been described previously (29, 30). Overexpression of PTP{alpha} reduced the total phosphotyrosine level of Fyn and more specifically, the level of the negative regulatory phosphotyrosine 529 of Fyn in CD45– T cells (Fig. 3A), suggesting a positive role for PTP{alpha} in Fyn activation. However, analysis of Fyn activity in an in vitro kinase assay (Fig. 3B, top panel) revealed that the presence of PTP{alpha} reduced Fyn activity, suggesting that PTP{alpha} can also negatively regulate Fyn activity. Overexpression of PTP{alpha} in the CD45+ T cells also reduced Fyn phosphorylation, indicating that both CD45 and PTP{alpha} can affect the phosphorylation state of Fyn. Interestingly, expression of PTP{alpha}-Y789F had a lesser effect on Fyn phosphorylation and Fyn activity compared with PTP{alpha} (Fig. 3A), even though expression levels of the two PTPs were similar (Fig. 3B, bottom panels). This demonstrates that PTP{alpha} and PTP{alpha}-Y789F differentially affect the phosphorylation state of Fyn in CD45+ and CD45– T cells and indicates that PTP{alpha} is more efficient at dephosphorylating Fyn than is PTP{alpha}-Y789F. In contrast, analysis of Lck immunoprecipitates from PTP{alpha} and PTP{alpha}-Y789F transfected cells did not reveal a major effect of either phosphatase on Lck phosphorylation (Fig. 3A), suggesting that Lck is not a major substrate for PTP{alpha}. Together, this suggests that PTP{alpha} acts primarily on Fyn in T cells.

Fyn has been implicated as a Cbp kinase (30), and we examined whether the altered in vitro activities of Fyn were consistent with the in vivo phosphorylation of this potential substrate. Indeed, immunoprecipitated Cbp from CD45– T cells exhibited enhanced phosphorylation and phosphorylation-dependent association with Csk, compared with Cbp from CD45+ T cells, and the overexpression of PTP{alpha} reduced these increases (Fig. 3B, middle panels). Compared with PTP{alpha}, overexpressed mutant PTP{alpha}-Y789F was less effective in reducing Cbp phosphorylation and the extent of Cbp-Csk association in the CD45– T cells. These findings demonstrate that PTP{alpha} more potently promotes Fyn and Cbp dephosphorylation than does PTP{alpha}-Y789F.

PTP{alpha}-Y789F Is Less Efficient than PTP{alpha} in Restoring CD3-induced Phosphorylation in CD45– T Cells—Transfection of PTP{alpha} into CD45– T cells has previously been shown to partially restore TCR/CD3 proximal signaling events (15). Here we compared the abilities of PTP{alpha} and PTP{alpha}-Y789F to restore TCR/CD3 signaling events by examining protein tyrosine phosphorylation after stimulation of the cells with anti-CD3 {epsilon} antibody for 1 and 10 min (Fig. 4). The rapid induction of tyrosine phosphorylation of Zap-70 and specific proteins of about 38 and 120 kDa was observed in the CD45+ T cells. No significant induction of phosphorylation was observed in CD45– T cells. Overexpression of PTP{alpha} in CD45– T cells partially restored all these signaling events, whereas PTP{alpha}-Y789F had only a very minor effect (Fig. 4). These data indicate that PTP{alpha}-Y789F is less efficient than PTP{alpha} in restoring TCR/CD3-mediated signaling events. Together, the data suggest that PTP{alpha}-Y789F is less efficient than PTP{alpha} in the dephosphorylation of Fyn, Cbp, and in restoring TCR/CD3 signaling events in CD45– T cells.


Figure 4
View larger version (73K):
[in this window]
[in a new window]

  		FIGURE 4.
Induction of protein tyrosine phosphorylation by TCR/CD3 stimulation of PTP{alpha} and PTP{alpha}-Y789F-transfected CD45– T cells. Cells (5 x 105) were stimulated with CD3{epsilon} mAb for the times indicated, then lysed, and the proteins separated by SDS-PAGE and transferred to a PVDF membrane. Phosphotyrosine proteins were identified by immunoblotting with an anti-phosphotyrosine mAb (PY-20). Molecular mass markers are indicated on the left in kDa. The membrane was stripped and reprobed with anti-phospho Zap-70, Zap-70, VSVG, and CD45 antibodies. The experiment was repeated three times.

 
PTP{alpha}-Y789F Is More Efficient than PTP{alpha} in Reducing CD44-mediated Pyk2 Phosphorylation—The data thus far are consistent with the possibility that PTP{alpha}-Y789F is a less efficient phosphatase than PTP{alpha}. To further investigate this, CD44-mediated Pyk2 phosphorylation and T cell spreading were examined in the PTP{alpha}- and PTP{alpha}-Y789F-transfected T cells. Pyk2 is a member of the focal adhesion kinase family expressed in T cells and has been implicated in cell adhesion and migration processes (31). CD44-mediated Pyk2 phosphorylation is dependent on SFK activity, yet is negatively regulated by CD45 (9). This is opposite to the role of CD45 in TCR/CD3 signaling where it has a positive regulatory action on Lck and is required for efficient stimulation (reviewed in Refs. 3–5). Here, PTP{alpha}- and PTP{alpha}-Y789F-transfected CD45– T cells were immobilized on CD44 antibody and cell spreading and Pyk2 phosphorylation compared with that of parental CD45– T cells. PTP{alpha}-transfected cells showed reduced cell spreading compared with the CD45– T cells, and spreading was even more strongly reduced in PTP{alpha}-Y789F-expressing CD45– T cells (Fig. 5A). Pyk2 phosphorylation was strongly induced in CD45– T cells after 2 h but was reduced in PTP{alpha}-expressing cells and almost abolished in PTP{alpha}-Y789F-expressing cells (Fig. 5B), indicating a direct correlation between the extent of Pyk2 phosphorylation and cell spreading. Notably, PTP{alpha}-Y789F-transfected cells showed lower induced levels of Pyk2 phosphorylation than PTP{alpha}-transfected cells. This is opposite to the effect of PTP{alpha} and PTP{alpha}-Y789F on the phosphorylation state of Fyn and Cbp where lower phosphorylation of these proteins was observed in PTP{alpha}-transfected cells. This suggests that phosphorylation of PTP{alpha} at tyrosine 789 can differentially influence the dephosphorylation of specific substrates and raises the possibility that phosphorylation at tyrosine 789 may regulate the substrate specificity of PTP{alpha}.

To further explore the possible mechanism for reduced Pyk2 phosphorylation in PTP{alpha}-Y789F transfected cells, immunoprecipitated Pyk2 was re-probed for associated PTP{alpha}. Surprisingly, PTP{alpha} but not PTP{alpha}-Y789F was found in the complex with Pyk2 both before and after CD44 stimulation (Fig. 5B). Furthermore, immunoprecipitation of PTP{alpha} and PTP{alpha}-Y789F at 0 and 2 h after CD44 stimulation revealed an association between Grb2 and PTP{alpha}, but not with PTP{alpha}-Y789F (Fig. 5C). Conversely, both PTP{alpha} and PTP{alpha}-Y789F associated with immunoprecipitated Fyn isolated from either CD45– or CD45+ T cells (Fig. 5D). This highlights two differences between PTP{alpha} and PTP{alpha}-Y789F, one in the ability of PTP{alpha} to co-immunoprecipitate Grb2 and the second in the ability to associate with Pyk2 in CD45– T cells.

Collectively, these data identify tyrosine 789 in PTP{alpha} as a site of phosphorylation in T cells and demonstrate that phosphorylation at this site is negatively regulated by CD45. CD45 can directly dephosphorylate PTP{alpha} at tyrosine 789 in vitro, raising the possibility that PTP{alpha} might be a substrate for CD45 in T cells. PTP{alpha}-Y789F-transfected CD45– T cells showed a reduced ability to dephosphorylate Fyn and restore TCR/CD3 signaling events, compared with PTP{alpha}-transfected CD45– T cells, suggesting that phosphorylation of PTP{alpha} at tyrosine 789 may facilitate the dephosphorylation of Fyn. Conversely, PTP{alpha}-Y789F had the greatest effect on reducing Pyk2 phosphorylation and reducing T cell spreading in CD45– T cells, suggesting that in this situation, PTP{alpha}-Y789F was the more efficient phosphatase. Together, these data demonstrate distinct activities of PTP{alpha} and PTP{alpha}-Y789F in T cells and identify CD45 as a regulator of PTP{alpha} phosphorylation at tyrosine 789 in T cells.


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
Although the role of CD45 in regulating Src family tyrosine kinases by regulating their phosphorylation is well established, its role in regulating protein tyrosine phosphatases by a similar mechanism has not previously been described. Here we provide evidence that PTP{alpha} is a target for CD45 in T cells. We establish that PTP{alpha} is phosphorylated at Tyr-789 in T cells and show that phosphorylation at this site is likely regulated by the balance of SFK and CD45 activities. In the absence of CD45, enhanced phosphorylation of PTP{alpha} is observed. This may be because of the dysregulation and enhanced activation of SFKs in the absence of CD45, as has been found in CD45-negative thymocytes (6, 32). In support of this, PTP{alpha} phosphorylation was significantly reduced by the SFK inhibitor PP2 in the CD45– T cells, suggesting an indirect effect of CD45 on PTP{alpha} phosphorylation via its action on SFKs. However, PTP{alpha} phosphorylation was abolished in the presence of PP2 in the CD45+ T cells, suggesting a direct, SFK-independent mechanism for CD45 in regulating PTP{alpha} phosphorylation. The possibility that CD45 can directly dephosphorylate PTP{alpha} is supported by the in vitro data. Thus it is likely that CD45 regulates PTP{alpha} phosphorylation by both a major, indirect mechanism and a minor, direct mechanism, the latter providing a novel example of the regulation of one receptor PTP by another.


Figure 5
View larger version (33K):
[in this window]
[in a new window]

  		FIGURE 5.
Effect of PTP{alpha} and PTP{alpha}-Y789F on CD44-mediated cell spreading. A, parental CD45– T cells (CD45–), PTP{alpha} (+wt{alpha}), and PTP{alpha}-Y789F (+Y789F) transfectants were immobilized for 2 h at 37 °C on either bovine serum albumin or anti-CD44 mAb-coated plates to induce cell spreading (see under "Experimental Procedures" for details). The scale bar represents 10 µm. The graph depicts the average cell length (µm ± S.E.) of at least 280 cells for each condition. *, average length of each cell type spread on CD44 mAb was significantly different (p < 0.001). B and C, 5 x 106 CD45– T cells and PTP{alpha} (wt {alpha}) and PTP{alpha}-Y789F (Y789F) transfectants were immobilized on CD44 mAb for the times indicated, then lysed in 1% Triton X-100 buffer, and Pyk2 (B) and PTP{alpha} (C) immunoprecipitated. Proteins were separated by SDS-PAGE and transferred to PVDF membrane where they were blotted for phosphotyrosine (4G10:PY-Pyk2 and PY-PTP{alpha}), PTP{alpha}, Pyk2, and Grb2. The line in C represents a deleted lane. D, Fyn was immunoprecipitated from CD45– and CD45+ T cells and PTP{alpha} (+wt{alpha}) and PTP{alpha}-Y789F (+Y789F) transfectants and immunoblotted for associated PTP{alpha}, as well as for Fyn to confirm the amounts of Fyn in each immunoprecipitate.

 
In non-hematopoietic cells (that lack CD45), about 20% of PTP{alpha} is constitutively phosphorylated at Tyr-789 (25), and PTP{alpha} Tyr-789 phosphorylation has been reported to play a role in PTP{alpha}-mediated mitotic activation of Src in fibroblasts (17, 33). Integrin stimulation in fibroblasts induces further phosphorylation of PTP{alpha} at Tyr-789, however this PTP{alpha} Tyr-789 phosphorylation is not required for integrin-induced PTP{alpha}-mediated SFK activation, although it is required for optimal cytoskeletal rearrangement and focal adhesion formation that determine cell migration (26). These contrasting results indicate that the phosphorylation of PTP{alpha} within its C-terminal tail can modulate PTP{alpha} function but that it may do so in a manner dependent upon signaling context. Here, the function of PTP{alpha} and the non-phosphorylated mutant PTP{alpha}-Y789F was compared in different signaling settings in T cells and revealed striking differences in their ability to affect the phosphorylation state of various potential PTP{alpha} substrates.

PTP{alpha} is expressed in various cell types and like CD45, is a well established regulator of SFKs (14). Recently, examination of thymocytes from PTP{alpha}-null mice revealed that Fyn and the potential Fyn substrate Cbp were hyperphosphorylated (16). Fyn was hyperphosphorylated at both the negative and positive regulatory sites in PTP{alpha}–/– thymocytes and was more active than Fyn from wild-type mouse thymocytes in an in vitro assay (16). Consistent with these findings, in the present study we observe that the overexpression of PTP{alpha} in CD45– T cells induces the dephosphorylation of Fyn and its substrate, Cbp. Fyn was dephosphorylated at the negative regulatory site yet its activity was decreased in an in vitro kinase activity. Interestingly, the mutant PTP{alpha}-Y789F was less effective than PTP{alpha} in causing Fyn and Cbp dephosphorylation and in reducing the in vitro kinase activity of Fyn, implicating a role for Tyr-789 phosphorylation in the regulation of Fyn by PTP{alpha} in T cells.

In contrast to its effect on Fyn, PTP{alpha} did not significantly affect the phosphorylation state of Lck, in accordance with the finding that Fyn but not Lck activity is altered in PTP{alpha}-null thymocytes (16). This may reflect a difference in location rather than a difference in substrate specificity as PTP{alpha} has been shown to specifically affect the activity of Fyn in lipid rafts (16). In that and in the present study, radioimmune precipitation assay buffer was used to solubilize Fyn from lipid rafts. This may explain why no major difference in Fyn phosphorylation was observed previously in PTP{alpha}-transfected CD45– T cells where Triton X-100 was used as the solubilizing agent (15). It is interesting to note that CD45 dramatically affects the phosphorylation state of Lck but not Fyn, whereas PTP{alpha} has the opposite effect. Given that CD45 may regulate PTP{alpha} activity, it is possible that CD45 may act indirectly on Fyn, or Fyn may be regulated by both the PTPs.

The location of these PTPs and SFKs is likely to play a role in their regulation and substrate specificity as CD45 and Lck are thought to reside primarily outside lipid rafts prior to T cell activation, whereas Fyn is enriched in lipid rafts along with the lipid raft resident protein, Cbp, and appears to be specifically regulated in rafts by a small population of raft-residing PTP{alpha}. However, these locations are not mutually exclusive as most of PTP{alpha} co-localizes with the majority of CD45 in the non-raft fraction (16), and only a minor population of CD45 can be detected in rafts (34), where it has been implicated in regulating Cbp phosphorylation (24). Cbp phosphorylation recruits Csk, a tyrosine kinase that phosphorylates the negative regulatory site of SFKs to counteract the activities of PTP{alpha} and CD45. Thus there appears to be an interacting network of self-regulating mechanisms designed to regulate SFK phosphorylation and prevent kinase overactivation.

Examination of TCR/CD3 signaling in PTP{alpha}-transfected CD45– T cells also revealed a stronger ability of PTP{alpha} to restore TCR signaling compared with PTP{alpha}-Y789F. This correlates with the increased ability of wild-type PTP{alpha} to reduce Fyn and Cbp phosphorylation. Analysis of mice deficient in Lck, Fyn, or both SFKs has determined that Lck is the predominant SFK required to initiate TCR signaling in thymocytes and mature T cells. However, current models of TCR activation put Fyn downstream of Lck activation, with Lck translocating to lipid rafts upon TCR stimulation to activate raft-associated Fyn (35, 36) by an as yet undetermined mechanism. An intriguing possibility is that PTP{alpha} is a target of Lck, thus promoting PTP{alpha} function as a Lck effector and a Lck/Fyn signaling intermediate.

Strikingly, PTP{alpha} and PTP{alpha}-Y789F exhibited reversed efficacies in modulating events in another signaling pathway, that of CD44-induced cell spreading. Pyk2 has been identified as a Fyn substrate in T cells (37), and previous studies have shown that CD44-mediated Pyk2 phosphorylation is dependent upon SFK activity, is negatively regulated by CD45, and correlates well with T cell spreading (9). The expression of PTP{alpha} in CD45– T cells demonstrated that like CD45, PTP{alpha} negatively affected CD44-mediated Pyk2 phosphorylation and cell spreading. However, in the CD44-stimulated T cells, PTP{alpha}-Y789F was more effective than PTP{alpha} in preventing Pyk2 phosphorylation and cell spreading. This suggests that either Pyk2 is a preferred substrate for PTP{alpha}-Y789F or that mutation at this site promotes access of the phosphatase to Pyk2. Alternatively, PTP{alpha} may be affecting Pyk2 phosphorylation indirectly, via its effect on Fyn. Either PTP{alpha} is more efficient at activating Fyn or PTP{alpha}-Y789F is more efficient at inactivating Fyn, by dephosphorylation at the autophosphorylation site. Given the fact that Fyn is able to phosphorylate Pyk2 in the absence of exogenous PTP{alpha}, we favor the explanation that PTP{alpha}-Y789F leads to the dephosphorylation of Pyk2, either directly or indirectly.

Interestingly, a clear difference in the abilities of PTP{alpha} and PTP{alpha}-Y789F to associate with Pyk2 and Grb2 was apparent both before and after CD44 stimulation. Mutation of Tyr-789 abolished the constitutive association observed between PTP{alpha} and Pyk2 and between PTP{alpha} and Grb2. The latter observation is in accordance with phospho-Tyr-789 being a Grb2-SH2 binding site (25, 38), but this is the first demonstration that PTP{alpha} can associate with Pyk2, although we do not know whether this interaction is direct or indirect. Grb2 has been shown to bind to Pyk2, although this was via Grb2 SH2 domain and phospho-Pyk2 (39). The complex of PTP{alpha} and Grb2 does not favor Pyk2 dephosphorylation implying that either Grb2 protects Pyk2 against dephosphorylation or that Grb2 hinders PTP{alpha} activity, as has been suggested (25, 38). Although further studies will be required to identify the precise mechanism, this clearly demonstrates that the mutant PTP{alpha}-Y789F can function differently to PTP{alpha}, which can be phosphorylated at this site. In addition, the modulatory effect of Tyr-789 is dependent on the signaling context in T cells.

Overall, these studies demonstrate the novel regulation of one PTP by another PTP. The data suggest that CD45 can both directly and indirectly affect the phosphorylation state of PTP{alpha} at Tyr-789 in T cells. We provide evidence that mutation at this site negatively affects the ability of PTP{alpha} to reduce the phosphorylation of Cbp and Fyn, to regulate the kinase activity of Fyn, and to restore TCR signaling events. Conversely, we find that mutation at this site enhanced the ability of PTP{alpha} to reduce Pyk2 phosphorylation and CD44-mediated cell spreading. This study provides the first evidence in T cells that mutation of this phosphorylation site can differentially modulate the function of PTP{alpha} in T cells.


   FOOTNOTES
 
* This work was supported by the Canadian Institutes of Health Research Grants MOP-49410 (to C. J. P.) and MOP-77712 (to P. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 Recipient of a Bertram Hoffmeister Postdoctoral Fellowship. Back

2 Recipient of a Child & Family Research Institute (CFRI) studentship and a Harry and Florence Dennison fellowship in Medical Research. Back

3 Holds a Child & Family Research Institute (CFRI) investigatorship award. Back

4 To whom correspondence should be addressed: Dept. of Microbiology and Immunology, 2350 Health Sciences Mall, Life Sciences Inst., University of British Columbia, Vancouver, BC V6T 1Z3, Canada. Tel.: 604-822-8980; Fax: 604-822-6041; E-mail: pauline{at}interchange.ubc.ca.

5 The abbreviations used are: PTP, protein tyrosine phosphatase; Cbp, Csk-binding protein; SFK, Src family kinase; TCR, T cell receptor; mAb, monoclonal antibody; HRP, horseradish peroxidase; PVDF, polyvinylidene difluoride; PIPES, 1,4-piperazinediethanesulfonic acid; PY, phosphotyrosine; a, active; i, inactive; VSVG, vesicular stomatitis virus glycoprotein. Back



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Mustelin, T., Coggeshall, K. M., and Altman, A. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 6302–6306[Abstract/Free Full Text]
  2. Chan, A. C., Desai, D. M., and Weiss, A. (1994) Annu. Rev. Immunol. 12, 555–592[CrossRef][Medline] [Order article via Infotrieve]
  3. Johnson, P., and Felberg, J. (2000) Mod. Asp. Immunobiol. 1, 156–159
  4. Alexander, D. R. (2000) Semin. Immunol. 12, 349–359[CrossRef][Medline] [Order article via Infotrieve]
  5. Hermiston, M. L., Xu, Z., and Weiss, A. (2003) Annu. Rev. Immunol. 21, 107–137[CrossRef][Medline] [Order article via Infotrieve]
  6. D'Oro, U., and Ashwell, J. D. (1999) J. Immunol. 162, 1879–1883[Abstract/Free Full Text]
  7. Ashwell, J. D., and D'Oro, U. (1999) Immunol. Today 20, 412–416[CrossRef][Medline] [Order article via Infotrieve]
  8. Deans, J. P., Kanner, S. B., Torres, R. M., and Ledbetter, J. A. (1992) Eur. J. Immunol. 22, 661–668[Medline] [Order article via Infotrieve]
  9. Li, R. H., Wong, N., Jabali, M. D., and Johnson, P. (2001) J. Biol. Chem. 276, 28767–28773[Abstract/Free Full Text]
  10. Ostergaard, H. L., and Trowbridge, I. S. (1990) J. Exp. Med. 172, 347–350[Abstract/Free Full Text]
  11. Mustelin, T., Pessa-Morikawa, T., Autero, M., Gassmann, M., Andersson, L. C., Gahmberg, C. G., and Burn, P. (1992) Eur. J. Immunol. 22, 1173–1178[Medline] [Order article via Infotrieve]
  12. Palacios, E. H., and Weiss, A. (2004) Oncogene 23, 7990–8000[CrossRef][Medline] [Order article via Infotrieve]
  13. Cloutier, J. F., and Veillette, A. (1999) J. Exp. Med. 189, 111–121[Abstract/Free Full Text]
  14. Pallen, C. J. (2003) Curr. Top. Med. Chem. 3, 821–835[CrossRef][Medline] [Order article via Infotrieve]
  15. Ng, D. H. W., Jabali, M. D., Maiti, A., Borodchak, P., Harder, K., Brocker, T., Malissen, B., Jirik, F. R., and Johnson, P. (1997) Biochem. J. 327, 867–876[Medline] [Order article via Infotrieve]
  16. Maksumova, L., Le, H. T., Muratkhodjaev, F., Davidson, D., Veillette, A., and Pallen, C. J. (2005) J. Immunol. 175, 7947–7956[Abstract/Free Full Text]
  17. Zheng, X. M., Resnick, R. J., and Shalloway, D. (2000) EMBO J. 19, 964–978[CrossRef][Medline] [Order article via Infotrieve]
  18. Bhandari, V., Lim, K. L., and Pallen, C. J. (1998) J. Biol. Chem. 273, 8691–8698[Abstract/Free Full Text]
  19. Kishihara, K., Penninger, J., Wallace, V. A., Kundig, T. M., Kawai, K., Wakeham, A., Timms, E., Pfeffer, K., Ohashi, P. S., Thomas, M. L., Furlonger, C., Paige, C. J., and Mak, T. W. (1993) Cell 74, 143–156[CrossRef][Medline] [Order article via Infotrieve]
  20. Felberg, J., and Johnson, P. (1998) J. Biol. Chem. 273, 17839–17845[Abstract/Free Full Text]
  21. Ng, D. H. W., Maiti, A., and Johnson, P. (1995) Biochem. Biophys. Res. Commun. 206, 302–309[CrossRef][Medline] [Order article via Infotrieve]
  22. Lim, K. L., Kolatkar, P. R., Ng, K. P., Ng, C. H., and Pallen, C. J. (1998) J. Biol. Chem. 273, 28986–28993[Abstract/Free Full Text]
  23. Ng, D. H. W., Watts, J. D., Aebersold, R., and Johnson, P. (1996) J. Biol. Chem. 271, 1295–1300[Abstract/Free Full Text]
  24. Davidson, D., Bakinowski, M., Thomas, M. L., Horejsi, V., and Veillette, A. (2003) Mol. Cell. Biol. 23, 2017–2028[Abstract/Free Full Text]
  25. den Hertog, J., Tracy, S., and Hunter, T. (1994) EMBO J. 13, 3020–3032[Medline] [Order article via Infotrieve]
  26. Chen, M., Chen, S. C., and Pallen, C. J. (2006) J. Biol. Chem. 281, 11972–11980[Abstract/Free Full Text]
  27. Thomas, M. L., and Brown, E. J. (1999) Immunol. Today 20, 406–411[CrossRef][Medline] [Order article via Infotrieve]
  28. Bain, J., McLauchlan, H., Elliott, M., and Cohen, P. (2003) Biochem. J. 371, 199–204[CrossRef][Medline] [Order article via Infotrieve]
  29. Hurley, T. R., Hyman, R., and Sefton, B. M. (1993) Mol. Cell. Biol. 13, 1651–1656[Abstract/Free Full Text]
  30. Ostergaard, H. L., Shackelford, D. A., Hurley, T. R., Johnson, P., Hyman, R., Sefton, B. M., and Trowbridge, I. S. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 8959–8963[Abstract/Free Full Text]
  31. Ostergaard, H. L., and Lysechko, T. L. (2005) Immunol. Res. 31, 267–282[CrossRef][Medline] [Order article via Infotrieve]
  32. Stone, J. D., Conroy, L. A., Byth, K. F., Hederer, R. A., Howlett, S., Takemoto, Y., Holmes, N., and Alexander, D. R. (1997) J. Immunol. 158, 5773–5782[Abstract]
  33. Zheng, X. M., and Shalloway, D. (2001) EMBO J. 20, 6037–6049[CrossRef][Medline] [Order article via Infotrieve]
  34. Edmonds, S. D., and Ostergaard, H. L. (2002) J. Immunol. 169, 5036–5042[Abstract/Free Full Text]
  35. Filipp, D., Leung, B. L., Zhang, J., Veillette, A., and Julius, M. (2004) J. Immunol. 172, 4266–4274[Abstract/Free Full Text]
  36. Filipp, D., Zhang, J., Leung, B. L., Shaw, A., Levin, S. D., Veillette, A., and Julius, M. (2003) J. Exp. Med. 197, 1221–1227[Abstract/Free Full Text]
  37. Qian, D. P., Lev, S., Vanoers, N. S. C., Dikic, I., Schlessinger, J., and Weiss, A. (1997) J. Exp. Med. 185, 1253–1259[Abstract/Free Full Text]
  38. Su, J., Batzer, A., and Sap, J. (1994) J. Biol. Chem. 269, 18731–18734[Abstract/Free Full Text]
  39. Blaukat, A., Ivankovic-Dikic, I., Gronroos, E., Dolfi, F., Tokiwa, G., Vuori, K., and Dikic, I. (1999) J. Biol. Chem. 274, 14893–14901[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
S. C. Chen, R. S. Khanna, D. C. Bessette, L. A. Samayawardhena, and C. J. Pallen
Protein tyrosine phosphatase-{alpha} complexes with the IGF-I receptor and undergoes IGF-I-stimulated tyrosine phosphorylation that mediates cell migration
Am J Physiol Cell Physiol, July 1, 2009; 297(1): C133 - C139.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. A. Samayawardhena and C. J. Pallen
Protein-tyrosine Phosphatase {alpha} Regulates Stem Cell Factor-dependent c-Kit Activation and Migration of Mast Cells
J. Biol. Chem., October 24, 2008; 283(43): 29175 - 29185.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/29/20925    most recent
M703157200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maksumova, L.
Right arrow Articles by Johnson, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maksumova, L.
Right arrow Articles by Johnson, P.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement